Results 31 to 40 of about 264,219 (265)
Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis [PDF]
, 2014 Recent evidence suggests that a mutation in the spike protein gene of feline coronavirus (FCoV), which results in an amino acid change from methionine to leucine at position 1058, may be associated with feline infectious peritonitis (FIP).
Tasker, S +21 more
core +1 more source
The Coronavirus Replicase [PDF]
, 2005 Coronavirus genome replication and transcription take place at cytoplasmic membranes and involve coordinated processes of both continuous and discontinuous RNA synthesis that are mediated by the viral replicase, a huge protein complex encoded by the 20-kb replicase gene. The replicase complex is believed to be comprised of up to 16 viral subunits and a
openaire +2 more sources
SSRN Electronic Journal, 2020 AbstractThis study examines racial disparities in the impact of the COVID‐19 pandemic in the United States, focusing on factors influencing infection and mortality rates at the county level. We find compelling evidence of disproportionate effects on ethnic minority groups, particularly Blacks, Hispanic Americans, and Native Americans.
Cong S. Pham, Devashish Mitra
openaire +1 more source
Insights into coronavirus immunity taught by the murine coronavirus
European Journal of Immunology, 2021 AbstractCoronaviruses (CoVs) represent enveloped, ss RNA viruses with the ability to infect a range of vertebrates causing mainly lung, CNS, enteric, and hepatic disease. While the infection with human CoV is commonly associated with mild respiratory symptoms, the emergence of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 highlights the potential for CoVs to ...
Sarah Grabherr +2 more
openaire +3 more sources
Frontiers in Medicine, 2021 Objective: We aimed to explore the dynamic changes in coagulation function and the effect of age on coagulation function in patients with pneumonia under admission and non-admission treatment.Methods: We included 178 confirmed adult inpatients with COVID-
Jiasheng Xu +17 more
doaj +1 more source
Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
Scientific Reports, 2022 A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk ...
Lloyd A. C. Chapman +8 more
doaj +1 more source
The Journal for Nurse Practitioners, 2020 COVID-2019 emerged from China in late December of 2019. It follows 2 other coronavirus outbreaks, the SARS-CoV and the MERS-CoV. Coronaviruses usually circulate among animals but sometimes can jump to humans. These 3 strains have caused severe disease in humans and global transmission concerns. Symptoms of COVID-2019 include cough, fever, and shortness
openaire +2 more sources
, 2007 Zust, Roland Cervantes-Barragan, Luisa Kuri, Thomas Blakqori, Gjon Weber, Friedemann Ludewig, Burkhard Thiel, Volker 5 R21 AI062246/AI/United States NIAID Research Support, N.I.H., Extramural Research Support, Non-U.S.
Thiel Volker +26 more
core +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 The COVID-19 disease presents a large range of clinical manifestations and includes asymptomatic, mild, and severe cases. The level of severity is related to parameters associated with immunity, genetics, and biochemistry.
Nadine N’dilimabaka +17 more
doaj +1 more source
Uirusu, 2003 SARS is a new type of infectious pneumonia that emerged in China in November 2002. It spread around the world through an outbreak in Hong Kong in March 2003. Patients were reported in 29 countries, and around 800 people died, although a majority of these cases were in Asian countries.
openaire +4 more sources